Bruker Executive and Leadership Team

Frank Laukien, the Chairman, President & Chief Executive Officer at Bruker, directs the overarching corporate strategy and operational execution across all business segments. Laukien guides the company's expansion in scientific instrumentation, analytical technologies, and diagnostic solutions, ensuring alignment with market demands in pharmaceuticals, biotechnology, and government sectors. This leadership role involves driving innovation in magnetic resonance, mass spectrometry, and microscopy systems, critical for advancing research and industrial applications. By overseeing global operations and strategic partnerships, Frank Laukien ensures Bruker maintains its position as a leader in providing advanced semiconductor metrology and defect-detection equipment, directly impacting the company's financial performance and market penetration worldwide. Laukien's strategic vision shapes Bruker's commitment to delivering high-performance superconducting materials for renewable energy and healthcare advancements.

Jonathan Nunez, the Chief Financial Officer at Bruker, manages the company's financial planning, reporting, and capital allocation strategies. Nunez oversees all fiscal operations, ensuring robust financial health across Bruker's global enterprise. This critical function involves optimizing resource deployment for research and development initiatives, particularly in areas like X-ray and atomic force microscopy systems. By directing financial operations, Jonathan Nunez supports the company's expansion into new markets and the enhancement of its diagnostic solutions portfolio. Nunez's responsibilities include managing investor relations and ensuring compliance with financial regulations, thereby safeguarding the company's assets and driving sustainable growth. The Chief Financial Officer's guidance is essential for Bruker's continued success in providing advanced analytical technologies to diverse industries.

Gerald Herman, the Executive VP & Chief Financial Officer at Bruker, collaborates with the Chief Financial Officer to manage the company's comprehensive financial architecture. Herman's executive oversight extends to financial strategy development and the execution of fiscal policies across Bruker's global operations. This role is pivotal in supporting the company's diverse product lines, from magnetic resonance systems to handheld X-ray fluorescence devices. By ensuring financial discipline, Gerald Herman contributes to Bruker's ability to invest in cutting-edge analytical technologies and diagnostic solutions. Herman's focus includes optimizing financial performance within the Bruker Scientific Instruments and Bruker Energy & Supercon Technologies segments. The Executive VP & Chief Financial Officer's expertise is vital for maintaining financial stability and enabling strategic growth initiatives.

Wulf Jung, the President PCI Division at Bruker, directs the strategic vision and operational execution for the company's life science mass spectrometry and chromatography businesses. Jung spearheads advancements in analytical technologies, focusing on mass spectrometry and ion mobility instruments that are crucial for pharmaceutical and biotechnology research. This leadership position involves driving product innovation and market expansion within the life sciences sector, ensuring Bruker's solutions meet the evolving needs of academic and industrial laboratories. By overseeing the PCI Division, Wulf Jung enhances the company's capabilities in providing sophisticated tools for drug discovery, clinical diagnostics, and food safety analysis. Jung's strategic direction ensures the division's contribution to Bruker's overall mission of advancing scientific understanding and improving human health.

Mark Munch, the President, Bruker BNANO Group at Bruker, leads the company's advanced nanoscale analysis and materials research instrumentation. Munch drives innovation in X-ray and atomic force microscopy systems, as well as superconducting materials, supporting critical applications in semiconductors, energy, and scientific research. This executive role involves expanding the group's portfolio of high-performance metrology and defect-detection equipment, essential for the semiconductor industry. By overseeing the BNANO Group, Mark Munch ensures the delivery of cutting-edge solutions that enable breakthroughs in materials science and nanotechnology. Munch's strategic leadership fosters collaboration across research institutions and industrial partners, reinforcing Bruker's commitment to technological advancement. The President, Bruker BNANO Group's focus on precision instrumentation is key to the company's market leadership.